Clemence Rougeaux

Dr. Clemence Rougeaux


Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
29 January 2021 in Toxins
Verified
Journal Article
Open access
PDF file
MDMaria Lucia Orsini Delgado
Maria Lucia Orsini Delgado
AAArnaud AVRIL
Arnaud AVRIL
JPJulie Prigent
Julie Prigent
JDJulie Dano
Julie Dano
ARAudrey Rouaix
Audrey Rouaix
SSStéphanie Simon
Stéphanie Simon
Ricin, a highly toxic protein from Ricinus communis, is considered a potential biowarfare agent. Despite the many data available, no specific treatment has yet been approved. Due to their ability to provide immediate protection, antibodies (Abs) are an approach of choice. However, their high specificity might compromise their capacity to protect against the different ricin isoforms (D and E) found in the different cultivars. In previous work, we have shown the neutralizing potential of different Abs (43RCA-G1 (anti ricin A-chain) and RB34 and RB37 (anti ricin B-chain)) against ricin D. In this study, we evaluated their protective capacity against both ricin isoforms. We show that: (i) RB34 and RB37 recognize exclusively ricin D, whereas 43RCA-G1 recognizes both isoforms, (ii) their neutralizing capacity in vitro varies depending on the cultivar, and (iii) there is a synergistic effect when combining RB34 and 43RCA-G1. This effect is also demonstrated in vivo in a mouse model of intranasal intoxication with ricin D/E (1:1), where approximately 60% and 40% of mice treated 0 and 6 h after intoxication, respectively, are protected. Our results highlight the importance of evaluating the effectiveness of the Abs against different ricin isoforms to identify the treatment with the broadest spectrum neutralizing effect.

21 March 2016 in Scientific Reports
Verified
Journal Article
Open access
CRClemence Rougeaux
Clemence Rougeaux
FBFrancois Becher
Francois Becher
EEEric Ezan
Eric Ezan
JTJean-Nicolas Tournier
Jean-Nicolas Tournier
PGPierre L. Goossens
Pierre L. Goossens
Lethal and edema toxins are critical virulence factors of Bacillus anthracis. However, little is known about their in vivo dynamics of production during anthrax. In this study, we unraveled for the first time the in vivo kinetics of production of the toxin components EF (edema factor) and LF (lethal factor) during cutaneous infection with a wild-type toxinogenic encapsulated strain in immuno-competent mice. We stratified the asynchronous infection process into defined stages through bioluminescence imaging (BLI), while exploiting sensitive quantitative methods by measuring the enzymatic activity of LF and EF. LF was produced in high amounts, while EF amounts steadily increased during the infectious process. This led to high LF/EF ratios throughout the infection, with variations between 50 to a few thousands. In the bloodstream, the early detection of active LF and EF despite the absence of bacteria suggests that they may exert long distance effects. Infection with a strain deficient in the protective antigen toxin component enabled to address its role in the diffusion of LF and EF within the host. Our data provide a picture of the in vivo complexity of the infectious process.

23 July 2020 in Microorganisms
Verified
Journal Article
Open access
PDF file
JTJean-Nicolas Tournier
Jean-Nicolas Tournier
CRClemence Rougeaux
Clemence Rougeaux
Anthrax toxins are produced by Bacillus anthracis throughout infection and shape the physiopathogenesis of the disease. They are produced in low quantities but are highly efficient. They have thus been long ignored, but recent biochemical methods have improved our knowledge in animal models. This article reviews the various methods that have been used and how they could be applied to clinical diagnosis.

31 January 2024 in Microorganisms
Verified
Journal Article
Open access
PDF file
ETEmilie Tessier
Emilie Tessier
LCLaurence Cheutin
Laurence Cheutin
AGAnnabelle Garnier
Annabelle Garnier
CVClarisse Vigne
Clarisse Vigne
JTJean-Nicolas Tournier
Jean-Nicolas Tournier
CRClemence Rougeaux
Clemence Rougeaux
Anthrax toxins are critical virulence factors of Bacillus anthracis and Bacillus cereus strains that cause anthrax-like disease, composed of a common binding factor, the protective antigen (PA), and two enzymatic proteins, lethal factor (LF) and edema factor (EF). While PA is required for endocytosis and activity of EF and LF, several studies showed that these enzymatic factors disseminate within the body in the absence of PA after intranasal infection. In an effort to understand the impact of EF in the absence of PA, we used a fluorescent EF chimera to facilitate the study of endocytosis in different cell lines. Unexpectedly, EF was found inside cells in the absence of PA and showed a pole-dependent endocytosis. However, looking at enzymatic activity, PA was still required for EF to induce an increase in intracellular cAMP levels. Interestingly, the sequential delivery of EF and then PA rescued the rise in cAMP levels, indicating that PA and EF may functionally associate during intracellular trafficking, as well as it did at the cell surface. Our data shed new light on EF trafficking and the potential location of PA and EF association for optimal cytosolic delivery.

12 June 2026 in Toxins
Verified
Journal Article
Open access
PDF file
AGAnnabelle Garnier
Annabelle Garnier
ETEmilie Tessier
Emilie Tessier
AAArnaud AVRIL
Arnaud AVRIL
CRClemence Rougeaux
Clemence Rougeaux
Ricin is considered a chemical and biological weapon. It is found in the seeds of a plant, Ricinus communis. There are different isoforms of ricin with different levels of toxicity, depending on the R. communis plant. There is no current prophylaxis and specific treatment for ricin poisoning is recent. Assessing potential countermeasures against this toxin still relies on testing on vertebrate animal models. Galleria mellonella larva, already used for the testing of bacteria, viruses, and fungi, represents an alternative model that is more ethical, inexpensive, and easier to use. In this study, we demonstrated for the first time the sensitivity of G. mellonella larvae to different cultivars of ricin. We observed mortality and a reduction in health index scoring over the days of testing. The health index scoring was based on the survival, the melanization, the mobility, and the capacity of larvae to produce a cocoon or not. Mortality was cultivar- and dose-dependent. Mortality of G. mellonella larvae was reduced when they were treated with a monoclonal antibody and concomitantly injected with ricin. Thus, G. mellonella represents a rapid and simple model of ricin poisoning, and, more particularly, a relevant model to test new therapeutics against ricin.